Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Portage Biotech Inc PRTG

Portage Biotech Inc. is a clinical-stage immuno-oncology company. The Company is engaged in advancing therapies to improve long-term treatment response, and quality of life in patients with cancers. The Company’s access to technologies coupled with biological mechanisms enables the identification of clinical therapies and product development strategies, which accelerate these medicines through... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:PRTG)

No current opinion is available.

Bullboard Posts (NDAQ:PRTG)

PRTG announced stock split 1-20

BREAKING NEWS: $PRTG PRTG announced stock split 1-202024-08-15 09:02:04 ET Portage Biotech Inc (PRTG) announced stock split at a ratio...
whytestocks - August 15, 2024

Portage Biotech Announces 1-for-20 Reverse Stock Split

Just In: $PRTG Portage Biotech Announces 1-for-20 Reverse Stock SplitWESTPORT, Conn., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Portage Biotech...
whytestocks - August 13, 2024

Portage Biotech Reports Updated Interim Data for Lead iNKT E

NEWS: $PRTG Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of...
whytestocks - June 5, 2023

Criminally undervalued

Long time holder here bought in when this was nothing but a penny stock on the OTC been through some ups and downs but imo this stock is...
aussyspitz - April 4, 2022

Sad

Legit stock being played. Baby Biohaven will come back and gift all of us. Sandy
Sandy60 - August 4, 2021

RE:Clear technical breakout ...

Well looks like the pump is over and this is destined to go back sub 10 once again and maybe in 2017 will be pumped again go back in...
pavelnedved - July 9, 2015